NCT00140712
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Macon, Georgia, United States
- GSK Investigational Site Chicago, Illinois, United States
- GSK Investigational Site Louisville, Kentucky, United States